E-DRUG: WHA side event 18 May: C-TAP: lessons learnt for future pandemic preparedness and response
---------------------------------------------------------------------------
Dear all,
I would like to invite you to our virtual side event to the WHA. Can I ask you to share this invitation widely in your networks as well? Thank you very much.
World Health Assembly virtual side event
Wed 18 May 2022, 15:00-16:30 CEST
Taking stock of C-TAP: lessons learnt for future pandemic preparedness and response
Join our World Health Assembly virtual side event on 18 May on the lessons learnt from the Covid-19 Technology Access Pool (C-TAP). The World Health Organization (WHO) launched this platform two years ago to enable developers of medical products against Covid-19 to share their intellectual property and know-how with other manufacturers in order to maximise production capacity. What has become of this ambition? And what is needed to unleash the potential of C-TAP, also for future pandemic preparedness and response?
Speakers
At the virtual side event, diverse stakeholders will share their experiences, insights and recommendations regarding C-TAP and/or a future technology sharing mechanism as part of global pandemic preparedness and response.
Invited speakers:
- Cristabal Cuadrado (Vice-Minister of Health Chile)
- Romain Macaya (former Executive President of the Costa Rican Social Security)
- Mark van Passel (Senior Policy Advisor Global Health Security at Dutch Ministry of Health, Welfare and Sport)
- Erika Duea±as Loayza (head of the intellectual property unit at WHO's division for access to medicines and health products)
- Esteban Burrone (Head of Policy at Medicines Patent Pool)
- James Love (Director of Knowledge Ecology International)
- Ellen 't Hoen (Director of Medicines Law & Policy)
- Irene Bernal (Senior Expert on Health and Social Policies at Salud Por Derecho, Spain)
Join us!
Time: 15:00-16:30 CEST
Please register via this link
https://us06web.zoom.us/webinar/register/WN_bzZwjMmVQ3qNIDm2Eompqg
This event is organised by the Covid-19 Innovations for All (CIFA) consortium, consisting of Wemos, Corporacian Innovarte, Knowledge Ecology International (KEI), Medicines Law & Policy, Health Action International (HAI) and the Pharmaceutical Accountability Foundation.
More information about this event:
https://www.wemos.nl/en/join-event-taking-stock-of-c-tap-lessons-learnt-for-future-pandemic-preparedness-and-response/#background
Background information
In May 2020, C-TAP was launched by the WHO, in partnership with the government of Costa Rica, under a Global Solidarity Call, endorsed by nearly 40 member states. The purpose of C-TAP is to provide a platform for developers of Covid-19 therapeutics, diagnostics, vaccines and other health products to voluntarily share their intellectual property, knowledge and data, with multiple quality-assured manufacturers. This would enable manufacturers that currently have untapped capacity to produce Covid-19 health products by giving them the legal rights to manufacture and sell the products; the technological know-how required to develop high-quality products effectively and efficiently; and access to clinical data needed to obtain regulatory approval for their products.
C-TAP works through its implementing partners, the Medicines Patent Pool (MPP), Open COVID Pledge, UN Technology Bank and Unitaid to facilitate timely, equitable and affordable access to Covid-19 health technologies. Developers of Covid-19 health technologies and holders of related knowledge, intellectual property and/or data are invited to voluntarily share these with C-TAP and join the Solidarity Call to Action.
Since its establishment, there has been a successful technology transfer agreement with the Spanish National Research Council (CSIC) for a Covid-19 serological antibody technology. There was however hope for much wider technology sharing by rights holders with C-TAP for improving global access to Covid-19 innovations. The purpose of this event is to take stock of C-TAP's impact to date with a view of sharing and reflecting on the factors influencing the number of successful technology transfer agreements, the good practices, challenges and lessons learnt for the future.
Kind regards,
Ella Weggen
Senior Global Health Advocate Wemos
"Ella Weggen | Wemos" <ella.weggen@wemos.nl>